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Purpose: To reduce cardiovascular risk through optimal obstructive sleep apnea (OSA) 
management with proactive screening utilizing the Epworth Sleepiness Scale (ESS) in male 
Veterans with hypertension (HTN) and diabetes mellitus (DM).  
Background: OSA is a common finding in primary care, with 1 in 5 adults feeling its effects: 
excessive sleepiness, impaired cognition, reduced quality of life and increased mortality. 
Unmanaged OSA has been highly correlated with increased cardiac risk in populations with 
chronic diseases such as HTN and DM. Fortunately, identification and treatment of OSA has 
been shown to improve cardiovascular outcomes and reduce mortality. Evidence supports 
outpatient screening to identify patients at risk for OSA, in order to more effectively manage 
future cardiovascular risk. 
Strategy and Implementation: Analyzing an existing database of 146 outpatient male veterans 
with HTN and DM, revealed that 52% have an existing OSA diagnosis, while the remainder 
have not been screened. The Doctor of Nursing Practice (DNP) student will screen these 
remaining patients for OSA via telephone utilizing the ESS tool. Based on findings, the DNP 
student will provide evidence-based guidance for further management of OSA to the care team.  
Evaluation/Outcomes: Post telephone screening intervention, the DNP student would expect a 
40-50% increase in completed OSA screenings by January 2018.   
Implications for Practice: Implementing proactive evidence-based OSA screening is the 
missing link in managing HTN and DM leading to improved cardiovascular outcomes for this 
Veteran population.  
Keywords: Obstructive sleep apnea, Epworth Sleepiness Scale, hypertension, diabetes mellitus, 





Obstructive sleep apnea (OSA) is a multifaceted and surprisingly common disease that 
occurs in one out of five adults in the United States. OSA is often underdiagnosed and 
subsequently undertreated due to its subtle presentation for both patients and providers 
(Gonzaga, Bertolami, Bertolami, Amodeo, & Calhoun, 2015). Screening for OSA in primary 
care is problematic as patients do not report sleep disturbances and providers do not routinely 
assessing for sleep-related symptoms (Miller & Berger, 2016). Thus, as little as 15% of patients 
with clinically significant OSA are identified and diagnosed (Miller & Berger, 2016). To further 
compound this issue, untreated OSA significantly contributes to the risk for developing and 
dying from cardiovascular disease and increased all-cause mortality (Gonzaga et al., 2015; Miller 
& Berger, 2016). 
OSA disturbs homeostasis by inducing intermittent hypoxemia, resulting in a surge of 
sympathetic activation and initiating a disruptive cascade that is evident in cardiovascular and 
metabolic processes. This disruption been shown to increase the risk for developing hypertension 
(HTN) and complicating treatment (Dempsey, Veasey, Morgan, & O'Donnell, 2010; Tanigawa, 
2011; Walia et al., 2014). Furthermore, OSA induced disruptions lead to poorer glycemic control 
via decreased insulin sensitivity, a higher risk for developing diabetes mellitus (DM), and more 
than doubles the risk of having an uncontrolled HgbA1C in diabetic patients (Muraki et al., 
2010; Torrella et al., 2015). 
There are 1.5 million veterans diagnosed with OSA in the United States today. These 
numbers are only increasing as OSA disease prevalence has doubled with the explosive 6-fold 
growth of this population in recent years (Bravata, Lightner, Yaggi, & Miech, 2018; Jackson et 
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al., 2017). Additionally, the veteran population is at an inherently increased risk for OSA due to 
the high proportion of males, increasing age, and prevalence of obesity (Bravata et al., 2018). 
This risk was demonstrated in an analysis of Mission Valley primary care male veterans with 
diagnoses of HTN and DM that revealed a majority (51%) of this population had a concurrent 
diagnosis of OSA. The remaining population was potentially at risk for OSA and was 
recommended to be screened (Moga, Burkard, Bittleman, & Hua Liu, 2017).  
Available Knowledge 
To support this evidence-based practice (EBP) screening project, a thorough literature 
search was completed using open access and subscription-based search engines provided through 
University of San Diego’s Copley Library. Search engines included CINAHL Plus with Full 
Text, PubMed, Google Scholar, Cochrane Database of Systematic Reviews, and Ovid. Search 
terms and medical subject headings included sleep apnea, obstructive sleep apnea, 
syndromes/complications, diabetes, hypertension, Veterans Health Administration, VA, veterans, 
primary care, screening sleep apnea, Epworth Sleepiness Scale. Articles included were published 
in the English language from the year 1995 to present. The initial search returned a total of 365 
articles and was narrowed based on subject content and relevance to 17. A total of 13 articles 
were used as evidence for the intervention. Of the articles selected, 8 were systemic reviews, 3 
randomized control trials, and one controlled cohort study. 
Provider assessment and screening of OSA symptoms (e.g., excessive daytime sleepiness 
[EDS]) are essential for diagnosis as reported by Miller and Berger (2016) in a systematic review 
of the available literature for screening and assessment of OSA in primary care. They reported 
that only 6% of patients present with sleep-related chief complaints in primary care due to the 
chronic and difficult-to-describe nature of the symptoms. Furthermore, they endorsed the 
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American Academy of Sleep Medicine recommendations reported by Epstein et al. (2009) for 
routine primary care screening of OSA, especially in high risk patients with HTN and DM. 
Additionally, they emphasized the importance of expedited referrals to sleep medicine for timely 
diagnosis and treatment for stabilization of the disease and for improved cardiovascular 
outcomes. 
Dempsey et al. (2010) provided a systematic review of the literature focusing on the 
pathophysiology of OSA. They noted that OSA induced transient obstruction of the upper 
airways, subsequent fluctuations in arterial oxygenation, and resulting intermittent hypoxemia 
leads to arousals during sleep with sympathetic nervous system overcorrection. They report these 
surges in sympathetic activation to complicate the treatment of chronic illnesses such as HTN 
and DM. Supporting the interrelation on OSA in patients with HTN and DM was found in the 
following studies. Gonzaga et al. (2015) in a systemic literature review investigated the 
interrelation between HTN and OSA. They discovered that 30-40% of hypertensive patients 
tested positive for OSA and 50% of patients with OSA were found be hypertensive, further 
indicating the need to screen patients with HTN for OSA. Muraki et al. (2010) In a large cohort 
study, associated nocturnal intermittent hypoxia with increased risk for the development of DM 
type 2 independent of age, sex, and body mass index. Aurora and Punjabi (2013) in a review of 
the literature identified a similar independent bidirectional association of DM type 2 and OSA 
and emphasized the need to routinely screen for OSA in patients with DM. 
The Epworth Sleepiness Scale (ESS) was designed by Johns (1991) to assess subjective, 
excessive daytime sleepiness (EDS) in patients. In his more recent review, Johns (2009) 
described EDS as a symptoms that occurs when a patient is expected to remain awake and alert 
during daytime activities but instead feels drowsy or falls asleep. He reports that the ESS is 
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designed as a retrospective recall of the patient’s dozing behavior in eight scenarios on a 0 
(Never) to 3 (Always) scale and a total score from 0 to 24 points. His review of the tool literature 
reported normal scores (M = 4.6; SD = 2.8) for populations without sleep disorders and 
determined that patients scoring above 10 points were recommended for further follow up. 
Hardinge, Pitson, and Stradling (1995) further confirmed EDS as a main presenting symptom of 
patients with undiagnosed OSA. For this reason, they reported the importance to routinely assess 
for EDS in patients with comorbidities such as HTN and DM in the primary care setting. Devine, 
Hakim, and Green (2005) in a systematic review of sleep dysfunction measurement tools noted 
the ESS as simple to use and interpret, with sufficient reliability and responsiveness, and 
validated in a variety of populations.  
The benefits of identifying and treating OSA for patients with HTN are demonstrated in a 
meta-analysis by Montesi, Edwards, Malhotra, and Bakker (2012). They determined that OSA 
treatment with continuous positive airway pressure (CPAP) yielded significant reductions in 
diurnal and nocturnal systolic/diastolic blood pressures when compared with placebo and sham 
CPAP therapy. The researchers also noted the impact of OSA treatment on population health 
with reductions in daytime sleepiness, driving risk, and increased longterm cardiovascular 
benefits. For diabetic patients with OSA, Torrella et al. (2015) in a non-randomized control trial, 
demonstrated improved nocturnal and postprandial peaks of interstitial glycemia with CPAP 
treatment. Marin, Carrizo, Vicente, and Agusti (2005) demonstrated long term reductions in 
cardiovascular risk with OSA treatment via CPAP in their prospective cohort study. Recruiting 
and following an age- and BMI-matched cohort of healthy men with and without OSA for a 
period of 12 years, fatal and non-fatal cardiac events were found to have increased in patients 
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with untreated severe OSA. Furthermore, they demonstrated that treatment with CPAP for at 
least 4 hours per night significantly reduce cardiovascular risk for those patients.   
After a careful search and analysis of the literature, there was sufficient evidence to 
support an ESS screening intervention to proactively assess for OSA in the primary care setting 
for patients with HTN and DM. In addition, evidence assessed is applied to provide evidence-
based recommendations for optimized disease management and cardiovascular risk aversion in 
OSA patients.  
Rationale 
The Iowa Model is scalable and well suited for implementing EBP projects in large multi-
hospital settings as well as in small primary care clinics. The model’s emphasis on assessing 
problem-focused triggers, organizational priority of the problem, and a sufficient evidence base 
will ensure the project is successful in the VA primary-care setting (Titler et al., 2001). Strengths 
of this model include its ease of use, application focus, and integration of the interdisciplinary 
team. Challenges with using this model include the potential for processes to become fragmented 
with built-in feedback loops and the introduction of multiple stakeholders can introduce 
unwanted complexities (Titler et al., 2001).  
The 5 A’s for Patient-centered Counseling (5As) model was utilized for the structure of 
this telephone screening intervention. The 5As is an evidence-based construct that was initially 
developed by the National Cancer Institute to assist providers in counseling for smoking 
cessation (Whitlock, Orleans, Pender, & Allan, 2002). The 5As has reported successful 
interventions in primary care and in a variety of health conditions and behaviors (Whitlock et al., 
2002). The success of the 5As lies in its simplicity and logical format representing behavior 
change as a cyclical pathway. The 5As pathway begins with Ask to assess patient behavior, 
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beliefs, and motivation followed by Advise for patient-specific health risks, then to Agree on a 
realistic set of goals, Assist with anticipated barriers, and finally to develop an action plan and 
Arrange follow-up support (Whitlock et al., 2002). With the evidence-based structure provided 
by the Iowa Model and guided by the 5As, the screening intervention was successful and 
provided important OSA screening to a high-risk population of veterans. 
Specific Aims 
 The primary outcome for this intervention was to increase screening for the remaining 70 
primary-care, male veterans with HTN and DM but without OSA. The short-term goal (30 days) 
was to screen 40%-50% of this group with the ESS by January 2018. The long-term goal (90 
days) was to provide evidence-based guidance to the care team for further management of OSA.  
Methods 
Context 
 The VA is the largest integrated health care system in the United States, with over 12,000 
health care facilities, 170 hospitals and approximately 1,000 outpatient clinics (U.S. Department 
of Veterans Affairs, 2018). The VA health care system spans coast-to-coast and provides the 
entire continuum of care for over 9 million Veterans (U.S. Department of Veterans Affairs, 
2018). The local VA Mission Valley primary care clinic was selected for implementing this EBP 
screening intervention due to physician and care team engagement, site willingness, and 
experience with EBP projects. The database used in this intervention was generated from the 
VA’s electronic health record (EHR) for Moga et al. (2017)’s DNP Project, “Evaluation of 
Hypertensive Clinical Significance in a Primary Care Setting in Veterans with Diabetes”. This 
dataset was further refined to male patients with diagnoses of HTN and DM without OSA. This 
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sub-group of patients was overall described as older, overweight, and with controlled HTN and 
DM (Tables 1 and 2).  
Potential project challenges due to contextual factors included the complexity and size of 
the VA Health Care system as whole as well as the integration of the interdisciplinary team for 
follow up to ensure ESS scores were assessed and referred as appropriate. 
Interventions 
 For this intervention, the DNP student functioned as a phone screener, data collector, and 
analyst. The care team, composed of the primary care physician and registered nurses, functioned 
in support roles and were the primary stakeholders in this project. The project implementation 
was divided into three stages: (a) in the first stage, the dataset used by the preceding DNP student 
was refined for the current project; (b) the second stage incorporated the telephone screening 
intervention, and (c) the third stage was analysis and reporting back to the care team.  
Stage 1 began in August 2017 by first refining and de-identifying the existing database of 
331 patients to focus on male patients with documented HTN and DM diagnoses. The database 
was further refined for patients without a diagnosis of OSA (Figure 1). The remaining 70 patients 
eligible for screening were cross-referenced in the VA’s EHR for contact information. A total of 
14 patients were excluded from the intervention due to non-working phone numbers or 
inaccessible charts flagged as “sensitive” in the EHR. Stage 2 began in late October 2017 by 
screening the remaining 56 eligible patients via phone with a standardized script incorporating 
the ESS and the 5As (Figure 2). Screening with the ESS produced a score of 0 to 24 for each 
patient and was recorded at the conclusion of the call. Missed calls were logged and voicemail 
messages were left with a callback number and time for a follow-up call by the DNP student. 
Any additional needs or concerns voiced by the patient during the screening intervention were 
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added to the log and reported back to the care team. For more urgent needs, the DNP student 
referred the patient to the clinic’s main number for more timely follow up. Stage 2 was 
concluded after 30 days of data collection with satisfactory screening rates exceeding projected 
goals. 
In the third and final stage of the intervention, the collected data were analyzed and 
results were presented to the stakeholders in mid-December 2017. Results were disseminated at 
two professional conferences in November 2017 and March 2018. Furthermore, the discussion 
section of this manuscript will provide further guidance to the care team regarding evidence-
based management of this high-risk population.  
Study of the Intervention 
For the intervention to be successful and the findings valid, it was important to assess and 
control for contextual factors at the VA Mission Valley clinic. For example, ensuring that there 
were no changes in the sleep health related standard of care, or concurrent projects during the 
intervention period offered creditability that the observed increase in screening could be directly 
attributed to the work done by this project.  
Measures 
To ensure data integrity and the ability to draw conclusions from the intervention, process 
monitoring was fundamental. To eliminate possible process fragmentation, the DNP student was 
responsible for database abstraction, patient screening, and data entry. The process of identifying 
patients in the database who met criteria for screening as well as pairing with contact information 
was important to complete early in the project to proceed with the intervention. During this 
process, to mitigate fatigue, database abstraction was divided over 2 days and processed in 
batches to ensure data quality and accuracy. This process was assessed initially and then weekly 
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for quality and discrepancies during data collection. Intervention call volume was high and 
accurate data entry proved to be an ongoing challenge. To assist with this process, collected data 
was entered immediately after screening and was audited for errors at the end of each working 
day. Finally, measurement of the overall ESS screening percentage was audited at the end of 
each week to ensure consistent screening rates and satisfactory progress towards project 
outcomes.  
Analysis 
The initial statistical analysis utilized R (Version 3.1.1) with an overlay of Radiant 
(Version 0.527) to run a linear regression analysis to assess for correlations with ESS score totals 
and continuous dataset demographics (e.g., blood pressure, A1C, disability rating). This analysis 
allowed the DNP student to visualize positive and negative correlations within the dataset to 
investigate for further analysis. Further regression analysis was performed with Excel Analysis 
ToolPak (Version 16.10) software providing item-specific statistical output.  
Establishing the risk profile of the screened patients was performed by calculating the 
mean ESS total for comparison to normalized populations and is displayed visually on a Box 
Plot and table (Figure 3, Table 3). Furthermore, to visually demonstrate EDS related risk at the 
individual level the ESS total score for each patient was arranged in ascending order and 
classified with corresponding EDS risk categories and displayed in a Bar Chart and table (Figure 
4, Table 4). Additionally, analysis of item responses was performed on patient scoring tendencies 
of the ESS and displayed in a frequency table (Table 5). Call volumes and screening attempts 
during the intervention were analyzed and shown in a table (Table 6). Variations within the data 
could be attributed to the small sample and scope of this intervention. Likewise, the dataset 
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provided a single data point and did not allow for trending of data or historical comparisons of 
the data collected.  
Ethical Considerations 
 This retrospective data analysis and screening intervention was approved by the 
Institutional Review Boards at both the Department of Veterans Affairs and the University of 
San Diego as an extension of the previous DNP projects H160114 and 2016-12-107, 
respectively. Permission for the use of the ESS tool was acquired from the Mapi Research Trust 
(Reference 126377) at no cost due to the unfunded academic nature of this project. Additionally, 
the author did not have any conflicts of interest to disclose with this project.  
Results 
 The screening intervention was successful with 47 (84%) of the 56 identified male 
patients with HTN, DM and without OSA were screened utilizing the ESS within the 30-day 
timeline; surpassing the goal of screening at least 50% of the population by January 2018 (Figure 
1). 
 Important changes to the intervention occurred in Stage 2 when the DNP student 
discovered that the clinic phone to be used to screen patients was unable to receive direct calls. 
To address this challenge, a VoIP account was added to the DNP student’s phone that allowed 
for a consistent phone number for patients to return missed screening calls. This process change 
was essential as patients could return calls directly to the DNP student, ensuring consistent 
follow up, and facilitating the success of the intervention.  
The average total of ESS scores for the screened population (M = 7.34; SD = 4.4) indicate 
an elevated EDS and an increased risk for OSA when compared to normalized populations 
(Figure 3, Table 3). Moreover, the high-risk characteristics of the screened population discovered 
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at baseline were reinforced by the findings of increased age (M = 67; SD = 9.8), overweight 
(MBMI = 29.61; SD = 4.56), along with a high prevalence of dyslipidemia (83%), chronic kidney 
disease (28%), and coronary artery disease (19%). 
Table 4 demonstrates the EDS risk stratification for the population screened with the 
ESS. Based on the outlined EDS categories, 40% of the population exhibited higher than normal 
daytime sleepiness with scores ranging from 6 to 10. Furthermore, 24% of the population 
exhibited mild to severe excessive daytime sleepiness with scores ranging from 11 to 24. (Figure 
4).   
Table 5 illustrates the distribution of patient scores for each of the eight scenarios. 
Scenarios with dramatic skews of scoring to “0” or “would never doze” were seen in Questions 
4, 6, and 8 with 66%, 91%, and 89% of the patients, suggesting this response indicated activities 
that respondents believed required more alertness. Items that were more focused on home, lying 
down to rest or after a meal were found to have an even distribution of scoring among 
respondents.  
In a multiple regression equation with the ESS score as the dependent variable, the only 
significant independent variable was the patient’s VA assigned disability rating (F = 5.863, p = 
.020). The correlation of ESS and disability rating was small (adj R2 = 0.096) but suggests 
further investigation may be warranted (Table 7). 
For this intervention, a total of 84 calls were made to 56 patients and screened with the 
ESS tool. At the conclusion of the intervention, a total of 47 (84%) patients were screened with a 
total of 66 calls, averaging 1.4 calls for each completed screening. For each screening call that 
connected the DNP student with a patient, the ESS was successfully completed 100% of the time 
(Table 6).  
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The remaining 9 (16%) patients that were not screened during the intervention could not 
be successfully reached via phone after numerous attempts. Patients received two follow up calls 
over the intervention period and, with each missed call, a voice mail was left for a total of 18 
calls. Of the unscreened patients, no call-backs to the DNP student were made during the 
intervention timeframe (Table 6).  
Discussion 
 Screening veterans with HTN and DM at risk for undiagnosed OSA with the ESS was 
successful with 84% of the target population screened within the intervention timeline. Important 
findings included the increased average ESS total of this group (M = 7.4; SD = 4.4) when 
compared with other normalized populations (M = 4.28; SD = .45) throughout the world. 
Applying the EDS classifications finds that 40% of the population was categorized with higher 
than normal daytime sleepiness (i.e., ESS score from 6-10) and 24% of the population exhibited 
abnormal amounts of EDS (i.e., ESS score from 11-24). 
Strengths of this intervention include a focus on implementation in primary care setting 
where providers are more likely to encounter patients with undiagnosed OSA (Miller & Berger, 
2016). Furthermore, this intervention explored the important interrelation between the diagnoses 
of HTN, DM, and OSA for improved disease management and cardiac risk aversion.  
Interpretation 
  The elevation of the screened population’s total ESS scores when compared to 
populations without sleep disorders demonstrated an increased risk for undiagnosed OSA. To 
compound this risk, veteran OSA epidemiological studies have correlated higher total ESS 
scores with increased severity of OSA and subsequent increase of cardiovascular and metabolic 
comorbidities (Samson, Casey, Knepler, & Panos, 2012). Given the established baseline elevated 
 
 17 
OSA risk for veterans as a population, the increased ESS scores collected places this population 
at considerable risk for undiagnosed OSA. This further reinforces the need to routinely screen 
patients with HTN and DM for OSA in the primary care setting. 
The low rates of assessment and diagnosis of OSA in primary care reported in other 
studies is similarly reflected in the screened population (Miller & Berger, 2016). Based on the 
recommended 10-point cutoff for a normal ESS score, nearly one-fourth of the screened 
population demonstrated an abnormal amount of EDS and without routine screening, these 
higher risk EDS groups would be overlooked. The remaining 40% of the population classified on 
the upper-end of normal daytime sleepiness (ESS 6-10) and while not scoring abnormally, 
warrants closer observation and clinical management by the care team.  
 Analysis of the scoring tendencies of the screened population demonstrated the 
intentional design of the ESS to represent situations with varying chance of dozing. Situations 
requiring more alertness, such as the Question 6 scenario, “talking with someone,” or Question 8, 
in a car . . . in traffic,” were scored in a corresponding manner by patients (Kendzerska, Smith, 
Brignardello-Petersen, Leung, & Tomlinson, 2014). Similarly, the Question 5 scenario, “lying 
down to rest,” required less alertness and was scored as such by many patients (Table 5). The 
author of the tool notes that all questions must be completed for the screening to be valid, thus 
the tool was designed to be flexible and to allow interpretation for a variety of patients (Johns, 
2009). This is seen in Questions 4 and 8, where the patient was asked to remember a time where 
they were “a passenger in a car” versus “in a car” in this manner the tool deliberately does not 
identify if the patient was the driver or a passenger and allowed patients who do not drive to 
complete the screening. The adaptability of the ESS permitted increased screening success in a 
diverse patient population, especially in older veterans who may no longer drive.  
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The statistical significance of a positive correlation in ESS total scores and the VA 
recorded disability rating could be attributed to the retrospective and subjective nature of the ESS 
scale. The ESS relied on the patient’s recall of potentially dozing in everyday situations and 
could overlap with the patient’s overall appraisal of their quality of life. Studies have shown that 
veterans reporting higher EDS also report lower perceived quality of life, this is especially 
evident in populations with sleep disorders in combination with chronic diseases (Alexander et 
al., 2016; Vinnikov, Blanc, Alilin, Zutler, & Holty, 2017). Thus, increasing EDS measured with 
the ESS in this intervention could likely be positively correlated to the increased disability rating 
and subsequent lower perceived quality of life in the screened veterans. 
Screening interventions via phone can be challenging. Contributing to the success of the 
intervention was the engagement of this veteran population. A unique theme observed during 
screening calls was the willingness to participate, not only for their own benefit, but also for the 
benefit of other veterans. This was demonstrated by the 100% screen completion of the calls 
answered or returned to the DNP student and the low amount of calls required to reach patients 
for screening (Table 7). Perhaps this willingness to participate derived from the cohesion of 
veterans as a population and greatly contributed to the success of this screening intervention.  
Assessing the cost to benefit analysis for this intervention was challenging as the total 
costs and potential savings of OSA treatment are not always directly measurable. Overall 
intervention cost was minimal (Figure 5), only requiring labor hours of the screener and 1 hour 
of training. Moreover, the ESS tool was used at no cost as it is integrated into the VA EHR. 
Potential cost savings were estimated by calculating the cost of OSA related hospitalizations 
associated with HTN (2.1%) and DM (2.9%) and were extrapolated to the veteran population of 
7% the United States (Leger, Bayon, Laaban, & Philip, 2012; National Center for Veterans 
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Analysis and Statistics, 2016). Overall, this intervention provides an estimated savings of $7.80 
initially and $11 to sustain for each dollar spent (Figure 6). This low cost and high benefit to the 
VA is attributed to the proactive nature of this screening intervention, to mitigate future costs by 
identifying OSA patients in primary care with HTN and DM. 
Strategies for Successful Obstructive Sleep Apnea Management  
 The final endpoint of this screening intervention was to provide the care team with 
evidence-based recommendations for the management of this population. Utilizing the current 
American Academy of Sleep Medicine guidelines for management of OSA in adults, CPAP is 
considered the most effective treatment to provide to splint open the upper airway to reduce the 
number of hypoxemic events during sleep (Epstein et al., 2009). Other alternative interventions 
to treat OSA are custom oral appliances that assist in maintaining airway patency, surgery for 
upper airway reconstruction, or behavioral changes including weight loss to a BMI less than 25, 
sleep positioning, and reducing or avoiding alcohol and sedatives before sleeping (Epstein et al., 
2009).  
Consistent CPAP therapy in patients with HTN has been demonstrated to significantly 
reduce both SBP and DBP when compared to other treatments modalities (Montesi et al., 2012). 
In addition, CPAP therapy has been shown to improve insulin sensitivity in patients starting at 
18% with 2 days of treatment and increasing to 31% after 3 months of treatment and with 
positive effects lasting for years in compliant patients (Dempsey et al., 2010). Moreover, CPAP 
treatment significantly reduces the risk for fatal and non-fatal cardiovascular events in patients 




The positive impact of CPAP on OSA and subsequent comorbidity is reliant on patient 
compliance and duration of the treatment. Reduction in cardiovascular risk has been shown with 
CPAP use for at least 4 hours per night (Marin et al., 2005). Veteran epidemiological studies 
have indicated that there is a challenge in compliance with CPAP treatment. Large scale studies 
have shown that a little over half of veterans were compliant with their prescribed CPAP 
regimen for more than three nights weekly (Samson et al., 2012). It is important for the care team 
to recognize the benefits of forming a realistic plan of care that meets the needs of patients and 
care providers and is realistic and achievable.  
 A patient centered approach is essential to promote CPAP adherence through patient 
engagement and education and is vital to treat OSA effectively (Hilbert & Yaggi, 2017). The 
emphasis is placed on partnering with the patient regarding the disease prevention and health 
promoting aspects of CPAP therapy. With a greater understanding of the benefits of CPAP the 
patient is able to make more informed choices in their care, resulting in greater compliance. 
Moreover combining educational interventions with family/partners support have shown to 
increase CPAP use by at least 30 minutes a night and increased overall adherence (at least 4 
hours a night) by 13% (Hilbert & Yaggi, 2017). Collaborating with the multidisciplinary team 
beyond the sleep lab is also recommended. Primary care providers are an essential link in 
identifying OSA risk factors, abnormal clinical findings and referring appropriately and are 
crucial to disease prevention and risk management in this population.   
Limitations 
Important limitations for this intervention can be attributed to the VA database utilized. 
The database was inherently outdated as it was single data point in the patient’s care continuum 
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when queried in 2017. This limitation was expected when working with a retrospective database 
and has the potential to limit the generalizability of the findings.   
Furthermore, the internal validity of the intervention could be limited by the absence of a 
validated, process measure to qualify success beyond the percentage of the total intervention 
population screened. The overall design of the intervention allowed for potential bias with a 
single DNP student screening, collecting, recording, and analyzing data. To mitigate this 
potential bias, the intervention was designed with multiple redundancies in the process and 
outcome measures, with an emphasis on the structure of the intervention and with close 
monitoring of the anticipated outcomes.  
Conclusions 
 At the conclusion of this screening intervention, the DNP student was able to demonstrate 
an integrated, cost-effective method to proactively screen for OSA in primary care. This 
screening intervention identified a male veteran population with HTN and DM who was at 
elevated risk for OSA at baseline and, when compared, to normal populations utilizing the ESS. 
To assist with disease management for the population, recommendations for OSA treatment with 
CPAP could minimize disturbances and improve HTN, DM, and cardiovascular outcomes. 
Additionally, delivering care in a patient-centered approach improved adherence to CPAP 
treatment and ultimately long-term health outcomes for OSA.  
 Based on the minimal cost of the intervention and the predicted benefits to population 
health, this intervention is expected to be sustainable. There is also the potential for a future DNP 
student to assess the impact of CPAP treatment over time on the screened population via serial 
ESS scores and with a health-related quality of life tool. Dissemination of this intervention to 
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similar VA primary care clinics is feasible due to the integrated and scalable nature of the VA 
health system infrastructure.  
Further study is needed on the interplay of OSA and comorbid conditions such as HTN 
and DM in controlled and demographically-matched populations to further reinforce the benefit 
of OSA treatment. In addition, further investigation into the cost of OSA at the population level 
may allow for a more accurate financial analysis of the downstream impact of untreated OSA.   
In addition to its stated screening goals, the intervention succeeded empowering the 
routine screening for OSA in this veteran population and more importantly to ask our heroes 
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Tables and Figures for Manuscript 
Table 1 
Demographic Measures of Screened Patients (n = 47) 
 
M SD 
Age (years) 67.04 9.88 
Body-mass index (kg/m2) 29.61 4.56 
VA Assigned Disability Rating (%)  31.91 38.82 
Systolic Blood Pressure (mm Hg) 126.57 15.30 
Diastolic Blood Pressure in (mm Hg) 73.85 13.06 
Hemoglobin A1C (%) 6.86 1.19 
 
Table 2 
Proportion of Co-morbidities in Screened Patients  
 
% 
Current tobacco use - Smoked/Chewed (%) 13 
Chronic Kidney Disease (%) 28 
Transient Ischemia/Cerebrovascular Attack (%) 9 
Congestive Heart Failure (%) 6 
Coronary Artery Disease (%) 19 
Dyslipidemia (%) 83 
Obstructive Sleep Apnea (%) 0 
Hypertension (%) 100 




ESS Scoring Totals of Screened and Normal Populations  
 
M SD n 
VA Population Screened 7.4 4.4 47 
UK 4.5 3.3 188 
Italy 4.4 2.8 54 
Turkey 3.6 3.0 60 
Australia  4.6 2.8 72 
Note. Normal population information from Izci et al. (2008); Johns and Hocking (1997); 







ESS Score EDS Risk Stratification (n = 47) 
 
n % 
Lower Normal Daytime 
Sleepiness (0-5) 
17 36 
Higher Normal Daytime 
Sleepiness (6-10) 
19 40 
Mild Excessive Daytime 
Sleepiness (11-12) 
8 17 
Moderate Excessive Daytime 
Sleepiness (13-15) 
1 1 
Severe Excessive Daytime 
Sleepiness (16-24) 
2 6 
















1. Sitting and reading  15 12 11 9 
2. Watching TV 13 15 12 7 
3. Sitting, inactive in a public 
place (e.g. a theater or a 
meeting) 
24 13 7 3 
4. As a passenger in a car for an 
hour without a break  
31 4 6 6 
5. Lying down to rest in the 
afternoon when circumstances 
permit 
9 11 10 17 
6. Sitting and talking to someone 43 4 0 0 
7. Sitting quietly after a lunch 
without alcohol  
14 10 17 6 
8. In a car or bus, while stopped 
for a few minutes in traffic 






Communication Attempts in Screened and Non-Screened Patients 
 
Screened  
(n = 47) 
Non-Screened 
(n = 9) 
Total Population 
(n = 56) 
Calls (Outgoing) 51 18 69 
Calls (Incoming) 15 0 15 
Calls per completed Screen 1.4 0 1.5 
Answer to Screening Completion (%) 100 0 84 


















df SS MS F Significance F
Regression 1 102.4852192 102.4852192 5.862841069 0.019558368
Residual 45 786.6211638 17.48047031
Total 46 889.106383
Coefficients Standard Error t Stat P-value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 6.155904739 0.792936051 7.763431525 7.63331E-10 4.55884955 7.752959927 4.55884955 7.752959927




Figure 1. Project process 
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Figure 2. Intervention screening script with the 5As and the ESS 
 
Phone Intervention Screening Script 
5 A’s Behavior Change Model and the Epworth Sleepiness Scale 
 
Ask: 
Hello my name is Aaron, I am a nurse calling from the VA Mission Valley and we are updating our patient data 
base and I would like to ask you a few questions about how tired you become in your day to day life activities.  
 
Assess: 
This screening is important to identify underlying obstructive sleep apnea. Treating obstructive sleep apnea can 
improve your health and management of diseases such as hypertension and diabetes. 
 
Screen with Epworth Sleepiness Scale via VA EHR.  
*The questionnaire contact information and permission to use: Mapi Research Trust, Lyon, 
France –Internet: https://eprovide.mapi-trust.org 
 
Advise: 
Research indicates that treating conditions such as hypertension and diabetes can be complicated with 
obstructive sleep apnea. Just by treating obstructive sleep apnea we can reduce blood pressure and decrease 
insulin resistance and allow you to live a healthier life. 
 
Agree: 
(Based on results) Formulate a care plan with the patient and with active listening, answer any questions about 
screening and results.  
Interpretation:  
 0-5 Lower Normal Daytime Sleepiness 
6-10 Higher Normal Daytime Sleepiness 
11-12 Mild Excessive Daytime Sleepiness 
13-15 Moderate Excessive Daytime Sleepiness 
16-24 Severe Excessive Daytime Sleepiness 
 
Arrange:  
(Based on results) Follow up with the care team with ESS results and any patient concerns/questions from 
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Figure 4. Epworth Sleepiness Scale risk stratification 
 
 























Individual Patients Screened 
ESS Score Distribution
Line Item Explanation of Cost Total Estimated Cost 
Screening patients without 
OSA diagnosis 
10 hours 
DNP student = Free 





1x DNP student = Free 
4x RN $35/hour $140 
Cost of ESS Tool Existing license for use in VA EHR $0 
Total Estimated Project Cost 
Total cost – training, tool cost 
and  
cost to sustain intervention 








Items Cost Explanation Savings 
Cost for OSA related 




($11,000,000 * 2.1% 
for HTN and 2.9% for 
DM) 
$660,000 




savings annually  
 
($3,850 monthly) 
Intervention (Initial) $490 $3,850 /$490 $7.8 saved for each $1 spent 
Intervention 
(Sustained) $350 $3,850 /$350 
$11 saved for each $1 
spent 
 
Figure 6. Cost benefit analysis (per month) 
